Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
About three weeks ago, on November 15th, the compliance industry had another “Oh God, not again!!!” moment. Because CMS had issued changes in the scope of the Open Payments program. For the compliance professionals already struggling with data collection and compilation following the first set of changes issued in August 2019, these latest changes in […]
In case you missed it, OIG recently published a report on its review of Open Payments data published by CMS. A key objective of this review was to “assess whether data published on the Open Payments website were missing data elements, were inaccurate, or were inconsistent.” OIG only reviewed the data published by CMS for […]
This blog carries on from our previous blog (Compliance Professionals, Are Your Findings Statistically Significant?) on the difference between correlation and causality. Causality is established when the following three conditions are met: a) Temporal Association: For Event A to cause Event B, B must follow A. You cannot establish causality if two events are occurring […]
In qordata’s most recent webinar, Ned Mumtaz revisited a concept mostly familiar to undergrads and professional statisticians. (And increasingly unfamiliar for the rest of us). The concept differentiated between correlation and causality. Corporate citizens tend to use ‘correlation’ as a blanket term for any variables that seem to have a corresponding relationship. As a compliance […]
As researchers tend to know, “No response is also a response.” This is an important consideration for compliance professionals, who often rely completely on quantifiable data as the basis for their decisions. To understand the full context behind a compliance metric, it is equally important to go a step beyond the visible and measurable and […]
We’ve written about changes introduced by the CMS in the reporting structure for applicable manufacturers and GPOs about ten months ago. We revisit those today, observing how those changes enable applicable medical drug and device manufacturers in the spend submission process. Data Entry Ease Submitting spend reports for entities overseas? Made R&D payments to HCPs […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use